Bioceres Crop Solutions (BIOX) Q1 2027 earnings summary

Executive summary

• 1Q27 revenue was $53.8 million, down 22% YoY, reflecting commercial phasing and stronger competition in Argentina.

• Net loss from continuing operations widened to $10.8 million from $4.7 million; Adjusted EBITDA fell to $5.3 million from $13.9 million, despite a second consecutive quarter of sequential improvement.

Financial highlights

• Gross profit declined 39% YoY to $18.8 million; gross margin fell to 35.0% from 45.0% on lower volumes and unfavorable mix.

• SG&A was $17.4 million and broadly stable despite inflationary pressure on the Argentine cost base in U.S. dollar terms.

• Operating profit was $0.9 million versus $9.7 million; financial result was a loss of $10.4 million versus $11.9 million.

Outlook and guidance

• Forward-looking priorities include operating performance and cash generation, cost and working-capital initiatives, and addressing capital structure and liquidity needs.

• Refinancing and liability-management activities and the outcome of pending litigation and disputes remain uncertain.